Invesco India Pharma And Healthcare Fund
The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of the companies in Pharmaceuticals, Healthcare and allied sectors
Growthvine rating: 1/5 — ranked #73 of 87 in category.
Fund basics
| Category | Equity: Sectoral |
|---|
| NAV | ₹9.12 (as of 2026-10-15) |
|---|
| AUM | ₹439 Cr |
|---|
| Expense ratio | 0.00% |
|---|
| Riskometer | Very High |
|---|
| Fund manager | Aditya Khemani |
|---|
| Exit load | 0.5% for redemption within 3 months |
|---|
Performance & risk
| Standard deviation | 0.00% |
|---|
| Max drawdown | 0.00% |
|---|
| Alpha | 0 |
|---|
| Beta | 0 |
|---|
Market cap allocation
| Large cap | 34.3% |
|---|
| Mid cap | 18.9% |
|---|
| Small cap | 46.9% |
|---|
Concentration
| Top 5 holdings | 43.2% |
|---|
| Top 10 holdings | 75.4% |
|---|
| Total holdings | 13 |
|---|
Top holdings
- Triparty Repo — 20.6%
- Max Healthcare Institute Limited — 9.6%
- Sun Pharmaceutical Industries Ltd. — 9.0%
- Sai Life Sciences Limited — 8.6%
- Apollo Hospitals Enterprises Ltd. — 8.0%
- Manipal Health Enterprises Limited — 8.0%
- Divis Laboratories Ltd. — 7.8%
- Global Health Limited — 7.0%
- Dr. Agarwals Health Care Limited — 6.3%
- Corona Remedies Limited — 6.1%
Top sectors
- Healthcare — 45.6%
- Pharma & Biotech — 41.4%
- Cash — 13.0%
Calendar-year track record
No calendar-year history.